O VNGOC, juntamente com o NYNGOC e a Unidade da Sociedade Civil do UNODC, está organizando um evento paralelo online à margem do Fórum de Parceria do ECOSOC 2023 em 31 de janeiro de 2023, às 8h30. O evento intitula-se: O papel central da sociedade civil nas políticas de drogas, COVID-19 e realização da Agenda 2030

Descrição Breve:

A Secretaria Executiva da Comissão Interamericana para o Controle do Abuso de Drogas (ES-CICAD) está buscando manifestações de interesse de especialistas no campo de alternativas ao encarceramento e integração social para serem treinados como Master Trainers para a entrega do currículo de Gerenciamento de Cuidados de Caso internacionalmente. Após a conclusão bem-sucedida do treinamento de treinadores, esses Master Trainers serão incluídos na lista de instrutores do Case Care Management e podem ser contatados para ministrar o treinamento quando agendado. Caso tenha interesse...

Dear friends and colleagues, 

The Commission on Narcotic Drugs is starting very soon! In fact, tomorrow, Monday, 14 March 2022. 

Once again, all sessions, as well as the side events, are to be held online due to the pandemic. The good thing about that means that, you can still follow the plenaries and the side events! That’s why we thought that you might appreciate having all the links in one place.

GENERAL LINKS TO FOLLOW CND

• Link to 65th session with general information on organizational arrangements: https://www.unodc.org/unodc/en/commissions/CND/session/65_Session_2022/65CND...

Hybrid effectiveness-implementation trial designs have become increasingly prevalent in implementation research. As hybrid designs enter their second decade of widespread use, the Frontiers in Health Services’ Implementation Science section launches a Research Topic to fuel the field’s discourse on the past, present, and future of hybrid designs in knowledge translation. Submissions are welcome of both Original and/or Brief Research, Review, Methods, and Perspective articles. The call addresses critical assessments of hybrid designs, innovative use of hybrid designs in current trials, and...